Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $63.25 million. The enterprise value is $241.53 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 54.06 million shares outstanding. The number of shares has increased by 15.02% in one year.
| Current Share Class | 54.06M |
| Shares Outstanding | 54.06M |
| Shares Change (YoY) | +15.02% |
| Shares Change (QoQ) | +1.41% |
| Owned by Insiders (%) | 2.82% |
| Owned by Institutions (%) | 32.54% |
| Float | 47.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | 0.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.14
| Current Ratio | 1.14 |
| Quick Ratio | 1.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.97 |
Financial Efficiency
Return on equity (ROE) is -341.04% and return on invested capital (ROIC) is -12.25%.
| Return on Equity (ROE) | -341.04% |
| Return on Assets (ROA) | -9.00% |
| Return on Invested Capital (ROIC) | -12.25% |
| Return on Capital Employed (ROCE) | -29.46% |
| Revenue Per Employee | $553,249 |
| Profits Per Employee | -$244,112 |
| Employee Count | 454 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.96% in the last 52 weeks. The beta is 1.08, so Cardlytics's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -68.96% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 1.86 |
| Relative Strength Index (RSI) | 36.55 |
| Average Volume (20 Days) | 1,003,962 |
Short Selling Information
The latest short interest is 6.39 million, so 11.82% of the outstanding shares have been sold short.
| Short Interest | 6.39M |
| Short Previous Month | 6.63M |
| Short % of Shares Out | 11.82% |
| Short % of Float | 13.50% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
In the last 12 months, Cardlytics had revenue of $251.18 million and -$110.83 million in losses. Loss per share was -$2.12.
| Revenue | 251.18M |
| Gross Profit | 111.46M |
| Operating Income | -49.82M |
| Pretax Income | -110.83M |
| Net Income | -110.83M |
| EBITDA | -24.84M |
| EBIT | -49.82M |
| Loss Per Share | -$2.12 |
Full Income StatementBalance Sheet
The company has $43.96 million in cash and $221.43 million in debt, giving a net cash position of -$177.47 million or -$3.28 per share.
| Cash & Cash Equivalents | 43.96M |
| Total Debt | 221.43M |
| Net Cash | -177.47M |
| Net Cash Per Share | -$3.28 |
| Equity (Book Value) | -4.70M |
| Book Value Per Share | -0.09 |
| Working Capital | 17.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$741,000 and capital expenditures -$578,000, giving a free cash flow of -$1.32 million.
| Operating Cash Flow | -741,000 |
| Capital Expenditures | -578,000 |
| Free Cash Flow | -1.32M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 44.37%, with operating and profit margins of -19.84% and -44.12%.
| Gross Margin | 44.37% |
| Operating Margin | -19.84% |
| Pretax Margin | -44.12% |
| Profit Margin | -44.12% |
| EBITDA Margin | -9.89% |
| EBIT Margin | -19.84% |
| FCF Margin | n/a |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.02% |
| Shareholder Yield | -15.02% |
| Earnings Yield | -173.01% |
| FCF Yield | -2.06% |
Analyst Forecast
The average price target for Cardlytics is $2.25, which is 92.31% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.25 |
| Price Target Difference | 92.31% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -6.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.05 |
| Piotroski F-Score | 3 |
